Neil Gregory Almstead
CHIEF TECHNICAL OPS OFFICER · PTC THERAPEUTICS, INC.
- 2024
- Jul 13, 2026
- 13
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Neil Gregory Almstead files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael Schmertzler - $6.47M in PTCT purchases and sales in the last 12 months
- Mark Elliott Boulding - $4.08M in PTCT purchases and sales in the last 12 months
- Matthew B. Klein - $3.60M in PTCT purchases and sales in the last 12 months
- Eric Pauwels - $2.61M in PTCT purchases and sales in the last 12 months
- Emma Reeve - $2.49M in PTCT purchases and sales in the last 12 months
- Allan Steven Jacobson - $2.13M in PTCT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Neil Gregory Almstead?
Neil Gregory Almstead is a corporate insider, tracked as CHIEF TECHNICAL OPS OFFICER of PTC THERAPEUTICS, INC. (PTCT). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Neil Gregory Almstead last file a Form 4?
The most recent primary Form 4 on record is dated 13 July 2026, one of 13 filings going back to 2024.
Has Neil Gregory Almstead been buying or selling stock?
Recorded transactions: 0 open-market purchases and 49 open-market sales ($23.72M) across all tracked filings.
